Aberrant Expression of NCAPG is Associated with Prognosis and Progression of Gastric Cancer.
Ding-Ping SunChih-Chan LinShih-Ting HungYi-Yu KuangYou-Cheng HseuChia-Lang FangKai-Yuan LinPublished in: Cancer management and research (2020)
Overall, the results reveal that NCAPG overexpression is a candidate prognostic biomarker and potential therapeutic target in GC.